Nouveau
NouvEau, a private R&D firm, creates patented health products from wine, including a unique 30:1 concentrate.
Founded
2004NouvEau, a private R&D firm, creates patented health products from wine, including a unique 30:1 concentrate.
NouvEau, founded as a private entrepreneurial research and development firm, focuses on creating innovative health products derived from wine. Its core mission is to leverage advanced scientific methods to transform wine by-products into valuable health solutions, with a vision to revolutionize the health and wellness industry. NouvEau's flagship product is a patented 30:1 wine concentrate enriched with functional ingredients like Vitamin B. The company aims to demonstrate its technology through commercial proof of concept, seeking to license or sell its intellectual property and products.
NouvEau boasts a portfolio of notable intellectual properties, including U.S. patents for by-products from fermentation still bottoms and pending patents for wine health mixtures. The company holds trademarks such as "Eau de Vin" in both the U.S. and internationally. Through its innovative approach and robust IP portfolio, NouvEau has made significant strides in the health product market, demonstrating the potential to impact the industry by offering unique, scientifically-backed health solutions.
Companies similar to Nouveau include Vinomis Laboratories, Brand New Brands, Dionysus Technology Concepts and Liquid Health Labs.
Nouveau was founded in 2004.
Nouveau's headquarters is located in Lafayette, IN, US.
Nouveau's most recent funding round was for $12k (USD) in January 2015.
As of Jan 27, 2015, Nouveau has disclosed funding of $12k (USD). Undisclosed round amounts are excluded.
Nouveau has 38 employees as of Feb 4, 2024.
Liquid Health Labs
